Biora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Biora Therapeutics

15/11/2024 14:01

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of $5.04​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-48.90.  The mean expectation of two analysts
for the quarter was for a loss of $3.85 per share. Wall Street
expected results to range from $-4.20 to $-3.50 per share.
    * Revenue was $32.00 thousand​; analysts expected $210.00
thousand. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of $5.04​.
    * The company reported a quarterly loss of $18.4 million.
    * Biora Therapeutics Inc shares had fallen by 52.6% this
quarter and lost 82.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Biora
Therapeutics Inc is 97.50 
This summary was machine generated from LSEG data November 15 at
02:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -3.85          -5.04          Missed
 Jun. 30 2024      -4.50          1.80           Beat
 Mar. 31 2024      -4.50          -1.40          Beat
 Dec. 31 2023      -5.95          -6.20          Missed